| |
| |
|
| Insider
Information: |
Chang Joseph Y |
| Relationship: |
Director |
| City: |
Provo |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,234 |
|
|
Indirect Shares
|
78,068 |
|
|
| Direct
Value |
$264,788 |
|
|
|
Indirect Value
|
$973,508 |
|
|
| Total
Shares |
99,302 |
|
|
| Total
Value |
$1,238,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NU Skin Enterprises Inc |
NUS |
Chief Scientific Officer |
2023-03-02 |
21,234 |
2023-03-02 |
78,068 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2013-10-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-10-24 |
4 |
D |
$10.75 |
$188,125 |
D/D |
(17,500) |
0 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-10-24 |
4 |
D |
$10.75 |
$496,156 |
I/I |
(46,154) |
0 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2003-10-31 |
4 |
S |
$15.57 |
$896,567 |
D/D |
(57,583) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2004-08-02 |
4 |
S |
$26.63 |
$932,050 |
D/D |
(35,000) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-03-15 |
4 |
S |
$21.65 |
$433,000 |
D/D |
(20,000) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-05-19 |
4 |
S |
$22.16 |
$221,600 |
D/D |
(10,000) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-06-15 |
4 |
AS |
$23.93 |
$478,600 |
D/D |
(20,000) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-09-15 |
4 |
S |
$21.23 |
$424,600 |
D/D |
(20,000) |
2,131 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-12-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
92,306 |
10,000 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-05-19 |
4 |
OE |
$8.00 |
$80,000 |
D/D |
10,000 |
12,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-10 |
4 |
AS |
$50.69 |
$349,423 |
D/D |
(6,869) |
14,814 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-02-15 |
4 |
D |
$49.65 |
$85,845 |
D/D |
(1,729) |
16,213 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-03-09 |
4 |
AS |
$51.55 |
$32,270 |
D/D |
(626) |
17,942 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
EVP, Chief Scientific Officer |
• – – |
2021-09-13 |
4 |
AS |
$47.41 |
$758,560 |
D/D |
(16,000) |
17,942 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-03-04 |
4 |
D |
$49.68 |
$24,790 |
D/D |
(499) |
18,568 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-02-18 |
4 |
AS |
$49.77 |
$55,991 |
D/D |
(1,125) |
19,067 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-09 |
4 |
AS |
$49.92 |
$495,756 |
D/D |
(9,931) |
19,922 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-02-15 |
4 |
D |
$48.81 |
$57,547 |
D/D |
(1,179) |
20,192 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-02-15 |
4 |
D |
$45.38 |
$89,898 |
D/D |
(1,981) |
21,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
S |
$40.44 |
$2,769,533 |
D/D |
(68,485) |
21,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
S |
$40.77 |
$1,019,250 |
D/D |
(25,000) |
21,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,557 |
21,371 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-10 |
4 |
OE |
$39.51 |
$69,577 |
D/D |
1,761 |
21,683 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-03-15 |
4 |
OE |
$6.56 |
$151,360 |
D/D |
20,000 |
22,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2005-06-15 |
4 |
OE |
$8.00 |
$160,000 |
D/D |
20,000 |
22,131 |
|
- |
|
140 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
